Cystatin C is a low-molecular-weight protein inhibitor found in blood serum and is an indicator of glomerular filtration in kidney function.
This test is done to assess GFR. Cystatin C may be a more reliable indicator of kidney function than creatinine. Cystatin C is independent of muscle mass and age and is not reabsorbed in the kidney. Measurements of cystatin C are not as common as creatinine measurements.
Young adults: <0.70 mg/mL (<2.9 μmol/mL)
Older adults (older than 60 years): <0.85 mg/mL (<3.5 μmol/mL)
Cystatin C can be used to estimate the GFR:
Source: HoekF. J ., KempermanF. A. W ., & KredietR. T . (2003). A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrology Dialysis Transplantation, 18, 20242031.
No fasting is required.
Obtain a 5-mL venous blood sample (heparin or EDTA).
Cystatin C levels abnormally increase in association with impaired kidney function and loss of kidney homeostasis, as in acute kidney injury, CKD, diabetic nephropathy, and infections.
Pretest Patient Care
Explain purpose and sampling procedure for cystatin C.
Assess for signs of abnormal kidney function (hypertension, pain, edema, uremia, disorders of urination, and urine composition). Some conditions have no symptoms of nephrotic syndrome.
Follow Chapter 1 guidelines for safe, effective, informed pretest care.
Posttest Patient Care
Review outcomes and provide the patient with support and counseling.
Explain follow-up testing and possible treatment for kidney disease.
See Chapter 1 guidelines for safe, effective, informed posttest care.